Millennium Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.85M | Sell |
510,828
-272,349
| -35% | -$2.05M | ﹤0.01% | 2249 |
|
|
2025
Q1 | $5.93M | Sell |
783,177
-50,785
| -6% | -$384K | ﹤0.01% | 1859 |
|
|
2024
Q4 | $10.2M | Buy |
833,962
+45,395
| +6% | +$553K | 0.01% | 1556 |
|
|
2024
Q3 | $13.2M | Buy |
+788,567
| New | +$13.2M | 0.01% | 1369 |
|
|
2024
Q1 | – | Sell |
-233,366
| Closed | -$2.38M | – | 4178 |
|
|
2023
Q4 | $2.38M | Sell |
233,366
-6,359
| -3% | -$64.8K | ﹤0.01% | 2371 |
|
|
2023
Q3 | $2.17M | Buy |
239,725
+50,652
| +27% | +$458K | ﹤0.01% | 2417 |
|
|
2023
Q2 | $2.03M | Sell |
189,073
-55,480
| -23% | -$597K | ﹤0.01% | 2512 |
|
|
2023
Q1 | $2.5M | Buy |
244,553
+30,284
| +14% | +$310K | ﹤0.01% | 2391 |
|
|
2022
Q4 | $2.26M | Buy |
214,269
+64,862
| +43% | +$684K | ﹤0.01% | 2630 |
|
|
2022
Q3 | $1.92M | Sell |
149,407
-172,277
| -54% | -$2.21M | ﹤0.01% | 2890 |
|
|
2022
Q2 | $4.12M | Buy |
321,684
+311,169
| +2,959% | +$3.99M | ﹤0.01% | 2320 |
|
|
2022
Q1 | $110K | Buy |
+10,515
| New | +$110K | ﹤0.01% | 4825 |
|
|
2021
Q4 | – | Sell |
-207,030
| Closed | -$4.67M | – | 5225 |
|
|
2021
Q3 | $4.67M | Sell |
207,030
-26,631
| -11% | -$601K | ﹤0.01% | 2254 |
|
|
2021
Q2 | $6.02M | Sell |
233,661
-170,175
| -42% | -$4.38M | ﹤0.01% | 1939 |
|
|
2021
Q1 | $16.8M | Buy |
+403,836
| New | +$16.8M | 0.01% | 920 |
|